**OPN** Annual Report 

The OPN online platform for the free and open dissemination of scientific research has proven to be difficult to develop. The charity’s trustees are all working on OPN on a part-time basis, and the COVID-19 pandemic has meant that progress has been limited over 2021. 

The trustees will continue to develop OPN over 2022. 

There is a continued need for such a platform. 

Signed 

Jack Griffiths (CEO) Milos Indjin (CTO) Connor Swales (Trustee) Anthony Sweeting (Trustee) 



|||||||||||**CC16a**<br>**Last year**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**- 0**<br>**- 0**<br>**- 0**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**- 0**<br>**- 0**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Endowment**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>OK<br>**Endowment**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Current value**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Current value**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**When due**<br>**(optional)**<br>Date of approval<br>2 February 2022|
|---|---|---|---|---|---|---|---|---|---|---|
|||**OPN**|||||**No(if any)**|||**CC16a**|
||||||||||||
|||**Receipts andpayments accounts**|||||||||
|||**For the period**<br>**from**||Period start date||**To**||Period end date|||
|||||6 April 2020||||5 April 2021|||
||||||||||||
||**Section A Receipts and payments**||||||||||
|||**Unrestricted**<br>**funds**||**Restricted funds**||**Endowment**<br>**funds**||**Total funds**||**Last year**|
|||**to the nearest      £**||**to the nearest £**||**to the nearest £**||**to the nearest £**||**to the nearest £**|
||**A1 Receipts**||||||||||
|||**- 0**||**-**||**-**||**-**||**-**|
|||**- 0**||**-**||**-**||**-**||**-**|
|||**- 0**||**-**||**-**||**-**||**-**|
|||**- 0**||**-**||**-**||**-**||**-**|
|||**- 0**||**-**||**-**||**-**||**-**|
|||**- 0**||**-**||**-**||**-**||**-**|
|||**- 0**||**-**||**-**||**-**||**-**|
|||**- 0**||**-**||**-**||**-**||**-**|
||**_Sub total_**_(Gross income for AR) _|<br>**- 0**||**-**||**-**||**-**||**-**|
||||||||||||
||**A2 Asset and investment sales,**<br>**(see table).**||||||||||
|||**- 0**||**- 0**||**- 0**||**-**|||
|||**- 0**||**- 0**||**- 0**||**-**||**- 0**|
||**_Sub total_**|<br>**- 0**||**- 0**||**- 0**||**-**||**- 0**|
||||||||||||
||**_Total receipts_ **|<br>**- 0**||**- 0**||**- 0**||**-**||**- 0**|
||||||||||||
||**A3 Payments**||||||||||
|||**- 0**||**-**||**-**||**-**||**-**|
|||**- 0**||**-**||**-**||**-**||**-**|
|||**- 0**||**-**||**-**||**-**||**-**|
|||**- 0**||**-**||**-**||**-**||**-**|
|||**- 0**||**-**||**-**||**-**||**-**|
|||**- 0**||**-**||**-**||**-**||**-**|
|||**- 0**||**-**||**-**||**-**||**-**|
|||**- 0**||**-**||**-**||**-**||**-**|
|||**- 0**||**-**||**-**||**-**||**-**|
||**_Sub total_ **|<br>**- 0**||**-**||**-**||**-**||**-**|
||||||||||||
||**A4 Asset and investment**<br>**purchases,(see table)**||||||||||
|||**- 0**||**- 0**||**- 0**||**-**|||
|||**- 0**||**- 0**||**- 0**||**-**|||
||**_Sub total_ **|<br>**- 0**||**- 0**||**- 0**||**-**||**- 0**|
||||||||||||
||**_Totalpayments_ **|<br>**- 0**||**- 0**||**- 0**||**-**||**- 0**|
||||||||||||
||**_Net of receipts/(payments)_ **|<br>**- 0**||**-**||**-**||**-**||**-**|
||**A5 Transfers between funds**|**- 0**||**-**||**-**||**-**||**-**|
||**A6 Cash funds lastyear end**|**- 0**||**-**||**-**||**-**||**-**|
||**_Cash funds thisyear end_ **|<br>**- 0**||**-**||**-**||**-**||**-**|
||||||||||||
||||||||||||
||**Section B Statement of assets and liabilities at the end of the period**||||||||||
||**Categories**|**Details**||||**Unrestricted**<br>**funds**||**Restricted funds**||**Endowment**<br>**funds**|
|||||||**to nearest £**||**to nearest £**||**to nearest £**|
||**B1 Cash funds**|||||**-**||**-**||**-**|
|||||||**-**||**-**||**-**|
|||||||**-**||**-**||**-**|
|||**_Total cash funds_**||||**-**||**-**||**-**|
|||(agree balances with receipts and payments<br>account(s))||||OK||||OK|
|||||||**Unrestricted**<br>**funds**||**Restricted funds**||**Endowment**<br>**funds**|
|||**Details**||||**to nearest £**||**to nearest £**||**to nearest £**|
||**B2 Other monetary assets**|||||**-**||**-**||**-**|
|||||||**-**||**-**||**-**|
|||||||**-**||**-**||**-**|
|||||||**-**||**-**||**-**|
|||||||**-**||**-**||**-**|
|||||||**-**||**-**||**-**|
||||||||||||
|||**Details**||||**Fund to which asset**<br>**belongs**||**Cost (optional)**||**Current value**<br>**(optional)**|
||**B3 Investment assets**|||||||**-**||**-**|
|||||||||**-**||**-**|
|||||||||**-**||**-**|
|||||||||**-**||**-**|
|||||||||**-**||**-**|
||||||||||||
|||**Details**||||**Fund to which asset**<br>**belongs**||**Cost (optional)**||**Current value**<br>**(optional)**|
||**B4 Assets retained for the**<br>**charity’s own use**|||||||**-**||**-**|
|||||||||**-**||**-**|
|||||||||**-**||**-**|
|||||||||**-**||**-**|
|||||||||**-**||**-**|
|||||||||**-**||**-**|
|||||||||**-**||**-**|
|||||||||**-**||**-**|
|||||||||**-**||**-**|
||||||||||||
|||**Details**||||**Fund to which**<br>**liability relates**||**Amount due**<br>**(optional)**||**When due**<br>**(optional)**|
||**B5 Liabilities**|||||||**-**|||
|||||||||**-**|||
|||||||||**-**|||
|||||||||**-**|||
|||||||||**-**|||
||||||||||||
||Signed by one or two trustees on behalf<br>of all the trustees|Signature||||Print Name||||Date of approval|
||The trustees confirm that no income<br>or expenses have been reported<br>during this financial year owing to the<br>online platform’s development.|||||Jack Griffiths||||2 February 2022|
||||||||||||
||||||||||||



